Clemastine for eye pain

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Aug 2015: Trial registered, NCT02521311
  2. 28 Feb 2017: Trial started, NCT02521311

The trials

NCT02521311: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

State
Under way
Phase
Phase 2
People
90 planned
Started
28 Feb 2017
Primary completion
Aug 2028
Arms
Clemastine
Results
None posted
  1. 13 Aug 2015: Trial registered
  2. 28 Feb 2017: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.